Neurocognitive benefits of second-generation antipsychotics versus placebo: Insufficient evidence based on a systematic review

Hiroyoshi Takeuchi; Sadhana Thiyanavadivel; Gagan Fervaha; Gary Remington

doi:10.1097/JCP.0000000000000662

Neurocognitive benefits of second-generation antipsychotics versus placebo: Insufficient evidence based on a systematic review

Hiroyoshi Takeuchi, Sadhana Thiyanavadivel, Gagan Fervaha, Gary Remington

Department of Psychiatry

Research output: Contribution to journal › Letter › peer-review

6 Citations (Scopus)

Original language	English
Pages (from-to)	274-276
Number of pages	3
Journal	Journal of Clinical Psychopharmacology
Volume	37
Issue number	2
DOIs	https://doi.org/10.1097/JCP.0000000000000662
Publication status	Published - 2017 Apr 1

ASJC Scopus subject areas

Psychiatry and Mental health
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/JCP.0000000000000662

Cite this

@article{7841f1cd34824c46b8124566448730a9,

title = "Neurocognitive benefits of second-generation antipsychotics versus placebo: Insufficient evidence based on a systematic review",

author = "Hiroyoshi Takeuchi and Sadhana Thiyanavadivel and Gagan Fervaha and Gary Remington",

year = "2017",

month = apr,

day = "1",

doi = "10.1097/JCP.0000000000000662",

language = "English",

volume = "37",

pages = "274--276",

journal = "Journal of Clinical Psychopharmacology",

issn = "0271-0749",

publisher = "Lippincott Williams and Wilkins",

number = "2",

}

TY - JOUR

T1 - Neurocognitive benefits of second-generation antipsychotics versus placebo

T2 - Insufficient evidence based on a systematic review

AU - Takeuchi, Hiroyoshi

AU - Thiyanavadivel, Sadhana

AU - Fervaha, Gagan

AU - Remington, Gary

PY - 2017/4/1

Y1 - 2017/4/1

UR - http://www.scopus.com/inward/record.url?scp=85010877071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010877071&partnerID=8YFLogxK

U2 - 10.1097/JCP.0000000000000662

DO - 10.1097/JCP.0000000000000662

M3 - Letter

C2 - 28129314

AN - SCOPUS:85010877071

VL - 37

SP - 274

EP - 276

JO - Journal of Clinical Psychopharmacology

JF - Journal of Clinical Psychopharmacology

SN - 0271-0749

IS - 2

ER -

Neurocognitive benefits of second-generation antipsychotics versus placebo: Insufficient evidence based on a systematic review

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this